Try our beta test site
50 studies found for:    University of Kentucky | Alzheimer's disease | United States, Kentucky
Show Display Options
Rank Status Study
1 Active, not recruiting Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease
Condition: Preclinical Alzheimer's Disease
Interventions: Drug: Gemfibrozil;   Drug: Placebo
2 Completed Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study
Condition: Alzheimer's Disease
Interventions: Drug: Valproic Acid;   Drug: Placebo
3 Completed Evaluation of the COGNISION(TM) System as an Event-related Potential (ERP) Collection System.
Condition: Alzheimer's Disease
Intervention:
4 Active, not recruiting A Pilot Study to Reduce Inappropriate Anticholinergic Prescribing in the Elderly
Condition: Alzheimer Disease
Intervention: Other: Arm 1 Education Session
5 Unknown  Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Condition: Alzheimer Disease
Interventions: Drug: alphatocopherol;   Drug: Selenium;   Drug: Placebo replacement for vitamin E;   Drug: Placebo replacement for Selenium
6 Terminated A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Bapineuzumab
7 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
8 Completed Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
Condition: Alzheimer's Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg;   Drug: Placebo Control;   Drug: Bapineuzumab 1.0 m/kg
9 Recruiting A Study of LY3314814 in Participants With Mild Alzheimer's Disease Dementia
Condition: Alzheimer's Disease
Interventions: Drug: LY3314814;   Drug: Placebo
10 Completed Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
Conditions: Memory Disorders;   Alzheimer Disease;   Dementia;   Cognitive Impairment;   Frontotemporal Dementia
Intervention: Device: COGNISION™ System
11 Completed
Has Results
Resveratrol for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Resveratrol;   Drug: Placebo
12 Active, not recruiting A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: AZD0530 100mg daily;   Drug: AZD0530 125mg daily;   Drug: Placebo
13 Completed Anti-Oxidant Treatment of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Vitamin E, Vitamin C, and Alpha-lipoic Acid;   Drug: Coenzyme Q;   Drug: Placebo capsules;   Drug: Placebo wafers
14 Completed ADNI: Alzheimer's Disease Neuroimaging Initiative
Condition: Alzheimer's Disease
Interventions: Procedure: Magnetic Resonance Imaging (MRI);   Procedure: Positron Emission Tomography (PET);   Procedure: Lumbar Puncture (LP)
15 Completed A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)
Condition: Alzheimer Disease
Interventions: Drug: Rofecoxib;   Drug: Naproxen
16 Completed Agitation in Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: Trazodone;   Drug: Haloperidol
17 Recruiting Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Conditions: Mild Cognitive Impairment (MCI);   Alzheimer's Disease (AD)
Intervention:
18 Completed Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Conditions: Mild Cognitive Impairment;   Alzheimer's Disease
Intervention:
19 Completed Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
Condition: Alzheimer Disease
Intervention: Drug: Simvastatin
20 Active, not recruiting Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
Condition: Alzheimer's Disease
Interventions: Drug: T-817MA-H;   Drug: T-817MA-L;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.